Arkolith/Funds/Silverback Asset Management LLC

Silverback Asset Management LLC

CIK 1278960
Holdings as of Mar 31, 2026·disclosed May 21, 2026·~51-day 13F lag·13F-HR/AAmended
Active Filer

Silverback Asset Management LLC holds a diversified book of 45 stocks worth $698.8M as of Q1 2026 (disclosed May 21, 2026, a ~45-day 13F lag). They also disclosed $148.6M in put options (a bearish bet) and $43.2M in call options (bullish), shown separately below and excluded from the equity book.

Build

Build on this 13F portfolio

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Build

Ask your agent what Silverback Asset Management LLC owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/1278960/holdings"
Ask your agent
Use Arkolith to show SILVERBACK ASSET MANAGEMENT LLC's latest
holdings, largest changes, and filing provenance.
Opened
0
new positions
Added to
0
existing
Trimmed
0
reduced
Sold out
0
exited

Holdings: largest first

Bars show each stock's share of the portfolio. Click a row for its position history.

45 positions
#SecurityValueShares% PortLast moveHistory
No holdings ingested yet
Showing 0 of 45 positions

Largest options & derivatives disclosed

Put / call positions from the 13F — totals include every disclosed option leg

Put notional (bearish)$148.6M
Call notional (bullish)$43.2M
TypeUnderlyingNotional valueUnderlying shares
PUT · bearishSS SPDR S&P 500 ETF TRUST-USSPY$97.6M150K
PUT · bearishISHARES RUSSELL 2000 ETFIWM$38.4M155K
CALL · bullishISHARES RUSSELL 2000 ETFIWM$24.8M100K
CALL · bullishDEFINIUM THERAPEUTICS INC$5.6M294K
CALL · bullishSPDR SERIES TRUST$5.5M100K
PUT · bearishSPDR SERIES TRUST$5.5M100K
PUT · bearishLUCID GROUP INCLCID$4.5M470K
CALL · bullishVIAVI SOLUTIONS INC$3.3M100K
PUT · bearishINVESCO EXCH TRADED FD TR II$2.3M112K
CALL · bullishPAR TECHNOLOGY CORP$2.0M150K
CALL · bullishEYEPOINT INCEYPT$1.3M100K
CALL · bullishKARYOPHARM THERAPEUTICS INC$557K100K
PUT · bearishINDIE SEMICONDUCTOR INC$322K100K
CALL · bullishGOSSAMER BIO INC$164K500K

13F filers disclose option positions at the market value of the underlying the contracts reference, not the premium paid. A put is a bearish bet (it gains if the stock falls); a call is bullish. “Underlying shares” is the share count the contracts control, not a share holding. These legs are excluded from the equity book, weighting, concentration and sector figures above.

Filing history

As-of date vs the date the SEC received each filing

QuarterAs ofFiledPositionsValueForm
Q1 2026Mar 31, 2026May 21, 202663$698.8M13F-HR/A
Q4 2025Dec 31, 2025Feb 17, 202658$683.8M13F-HR
Q3 2025Sep 30, 2025Nov 13, 202568$1.0B13F-HR
Q2 2025Jun 30, 2025Aug 13, 202565$706.9M13F-HR
Q1 2025Mar 31, 2025May 15, 202561$724.2M13F-HR
Q4 2024Dec 31, 2024Feb 27, 202570$667.5B13F-HR/A
Q3 2024Sep 30, 2024Nov 14, 202483$743.6B13F-HR
Q2 2024Jun 30, 2024Aug 14, 202484$812.8B13F-HR
Q1 2024Mar 31, 2024May 14, 202479$750.6M13F-HR
Q4 2023Dec 31, 2023Feb 13, 202488$718.4M13F-HR
Q3 2023Sep 30, 2023Nov 14, 202392$729.5M13F-HR
Q2 2023Jun 30, 2023Oct 6, 202397$733.2M13F-HR/A
Q1 2023Mar 31, 2023May 15, 202399$737.3M13F-HR
Q4 2022Dec 31, 2022Feb 14, 2023131$724.6M13F-HR
Q3 2022Sep 30, 2022Mar 2, 2023134$705.9M13F-HR/A
Q2 2022Jun 30, 2022Aug 15, 2022107$649.2M13F-HR
Q1 2022Mar 31, 2022May 13, 202295$737.6M13F-HR
Q4 2021Dec 31, 2021Feb 14, 202279$836.8M13F-HR
Q3 2021Sep 30, 2021Nov 15, 202181$681.3M13F-HR
Amended / restated
  • Q1 2026 · filed May 14, 202613F-HR · superseded
  • Q4 2024 · filed Feb 13, 202513F-HR · superseded
  • Q2 2023 · filed Aug 17, 202313F-HR/A · superseded
  • Q2 2023 · filed Aug 14, 202313F-HR · superseded
  • Q3 2022 · filed Nov 14, 202213F-HR · superseded

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.